Incisionless fluorescent cholangiography (IFC): a pilot survey of surgeons on procedural familiarity, practices, and perceptions.
Bile duct injury
Fluorescence-guided surgery
Incisionless fluorescent cholangiography
Intraoperative radiologic cholangiography
Laparoscopic cholecystectomy
Near-infrared fluorescence
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
01
02
2019
accepted:
29
04
2019
pubmed:
8
5
2019
medline:
27
10
2020
entrez:
8
5
2019
Statut:
ppublish
Résumé
Incisionless fluorescent cholangiography (IFC) has recently been proven feasible, safe, and efficacious as an intraoperative procedure to help identify extrahepatic bile ducts during laparoscopic cholecystectomies (LC). We conducted a pilot survey of 51 surgeons attending an international conference who perform endoscopic cholecystectomies to identify their typical LC practices, and perceptions of IFC. An international panel of ten IFC experts, all with > 500 prior IFC procedures and related research publications, convened during the 4th International Congress of Fluorescence-Guided Surgery in Boca Raton, Florida in February 2017. The panel was charged with developing questions about LC practices and experience with IFC, and perceptions regarding its advantages, barriers to use, and indications. These questions then were asked to other congress attendees during one of the didactic sessions using an online polling application. Attendees, who ranged from zero to considerable experience performing IFC, accessed the survey via their portable devices. Of the 51 survey participants, 51% were from North America; 77% identified themselves as general/minimally invasive surgeons, and roughly 60% performed under 50 cholecystectomies/year. Only 12% performed routine intraoperative cholangiography (IOC), while 72.3% routinely performed critical safety reviews. Thirty-five percent estimated that their institution's laparoscopic-to-open surgery conversion rate was > 1% during LC. Roughly 95% of respondents felt that surgeons should have access to a noninvasive method for evaluating extrahepatic biliary structures; 84% felt that the most advantageous characteristic of IFC is the lack of any biliary-tree incision; and 93.3% felt that IFC would have considerable educational value in surgical training programs; and 78% felt that any surgeon who performs LC could benefit. Surgeons who participated in our survey overwhelmingly recommended the routine use of IFC during laparoscopic cholecystectomy as a complimentary imaging technique. Prospective randomized clinical trials remain necessary to determine whether IFC reduces the incidence of bile duct injuries and other LC complications.
Sections du résumé
BACKGROUND
Incisionless fluorescent cholangiography (IFC) has recently been proven feasible, safe, and efficacious as an intraoperative procedure to help identify extrahepatic bile ducts during laparoscopic cholecystectomies (LC). We conducted a pilot survey of 51 surgeons attending an international conference who perform endoscopic cholecystectomies to identify their typical LC practices, and perceptions of IFC.
METHODS
An international panel of ten IFC experts, all with > 500 prior IFC procedures and related research publications, convened during the 4th International Congress of Fluorescence-Guided Surgery in Boca Raton, Florida in February 2017. The panel was charged with developing questions about LC practices and experience with IFC, and perceptions regarding its advantages, barriers to use, and indications. These questions then were asked to other congress attendees during one of the didactic sessions using an online polling application. Attendees, who ranged from zero to considerable experience performing IFC, accessed the survey via their portable devices.
RESULTS
Of the 51 survey participants, 51% were from North America; 77% identified themselves as general/minimally invasive surgeons, and roughly 60% performed under 50 cholecystectomies/year. Only 12% performed routine intraoperative cholangiography (IOC), while 72.3% routinely performed critical safety reviews. Thirty-five percent estimated that their institution's laparoscopic-to-open surgery conversion rate was > 1% during LC. Roughly 95% of respondents felt that surgeons should have access to a noninvasive method for evaluating extrahepatic biliary structures; 84% felt that the most advantageous characteristic of IFC is the lack of any biliary-tree incision; and 93.3% felt that IFC would have considerable educational value in surgical training programs; and 78% felt that any surgeon who performs LC could benefit.
CONCLUSIONS
Surgeons who participated in our survey overwhelmingly recommended the routine use of IFC during laparoscopic cholecystectomy as a complimentary imaging technique. Prospective randomized clinical trials remain necessary to determine whether IFC reduces the incidence of bile duct injuries and other LC complications.
Identifiants
pubmed: 31062156
doi: 10.1007/s00464-019-06814-x
pii: 10.1007/s00464-019-06814-x
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
675-685Références
Surg Endosc. 2013 Apr;27(4):1051-4
pubmed: 23355163
Korean J Hepatobiliary Pancreat Surg. 2014 Aug;18(3):69-72
pubmed: 26155253
J Am Coll Surg. 2010 Jul;211(1):132-8
pubmed: 20610259
J Hepatobiliary Pancreat Surg. 2002;9(5):543-7
pubmed: 12541037
Dan Med J. 2014 Aug;61(8):A4891
pubmed: 25162446
Br J Surg. 2012 Feb;99(2):160-7
pubmed: 22183717
Ann Surg. 2019 Dec;270(6):992-999
pubmed: 30614881
G Chir. 2003 Apr;24(4):123-8
pubmed: 12886750
Surg Today. 2010 Jun;40(6):507-13
pubmed: 20496131
Lancet. 2015 Apr 27;385 Suppl 2:S38
pubmed: 26313086
Surg Endosc. 2017 Jun;31(6):2483-2490
pubmed: 27778170
Acta Chir Belg. 2019 Aug;119(4):236-242
pubmed: 30253694
J Gastrointest Surg. 2012 Sep;16(9):1814-5
pubmed: 22752550
World J Gastroenterol. 2015 Jul 7;21(25):7877-83
pubmed: 26167088
J Hepatobiliary Pancreat Sci. 2017 Jan;24(1):24-32
pubmed: 28026137
Int J Biomed Imaging. 2012;2012:940585
pubmed: 22577366
J Am Coll Surg. 1995 Jan;180(1):101-25
pubmed: 8000648
Surg Endosc. 2014 Jun;28(6):1838-43
pubmed: 24414461
Obes Surg. 2016 Mar;26(3):525-30
pubmed: 26224370
Chirurgia (Bucur). 2016 Jan-Feb;111(1):26-32
pubmed: 26988536
Expert Rev Med Devices. 2017 Jan;14(1):75-82
pubmed: 27899040
World J Surg. 2014 Nov;38(11):2813-7
pubmed: 24898936
Ann Surg. 2003 Apr;237(4):460-9
pubmed: 12677139
Can Fam Physician. 2012 Apr;58(4):e225-8
pubmed: 22611609
Am J Surg. 1993 Apr;165(4):505-7
pubmed: 8480891
Surg Endosc. 2017 May;31(5):2007-2016
pubmed: 28364147
Surg Endosc. 2015 Jun;29(6):1621-6
pubmed: 25277476
Kathmandu Univ Med J (KUMJ). 2015 Apr-Jun;13(50):130-3
pubmed: 26643829
J Long Term Eff Med Implants. 2005;15(3):329-38
pubmed: 16022643
BMC Surg. 2017 Apr 17;17(1):39
pubmed: 28412956
Ann Surg. 2018 Jul;268(1):143-150
pubmed: 28426479
Ann Surg. 2001 Oct;234(4):549-58; discussion 558-9
pubmed: 11573048